Biden’s 2024 Ambition: President Announces Intent to Pursue Second Term
On Monday, U.S. President Joe Biden said he plans to run for Presidency in 2024 but was not prepared to announce it yet.
Sarepta Therapeutics Announces That The Date Of The Advisory Committee Meeting For SRP-9001 Will Be May 12, 2023
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the date of the U.S. Food and Drug Administration's Cellular, Tissue and Gene Therapies
ABVC BioPharma Provides ABV-1601 Update On Phase I Site Initiation Visit Conducted At Cedars-Sinai Medical Center
ABVC BioPharma, Inc. (NASDAQ:ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that the Phase 1 Site Initiation Visit
Twitter, Uber, Investors, Cannabis Companies And Advocates Converging Soon In Miami
The Benzinga Cannabis Capital Conference, renowned as the world’s largest and most successful cannabis investing and finance event is being held at the iconic Fountainbleu Hotel in Miami Beach on April 11-12, 2023
Benzinga Buzz: MrBeast Is A Goodfella. Plus, Minecraft, Snoop Dogg, LeBron James And More.
Each week, Benzinga compiles the latest entertainment news into a cohesive column for your consideration. Read on for the latest updates — both useful and irreverent.
Tiger Woods, Scottie Scheffler, Rory McIlroy, Justin Thomas: Best Bets To Win 2023 Masters, ‘A Tradition Unlike Any Other’
Eighty-eight of golf's finest players are teeing off Thursday in the 87th Masters Tournament, one of four major tournaments and arguably the most prestigious of them all.
GeoVax Announces Presentation Of Preliminary Data From Clinical Trial Of Next-Generation COVID-19 Vaccine Candidate
Analysis of Open-Label Portion of Ongoing Phase 2 Trial of GEO-CM04S1
Presented at 23rd Annual World Vaccine Congress
Atlanta, GA, April 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax
Revolution Medicines To Present Preclinical Data At The Upcoming American Association For Cancer Research Annual Meeting 2023
Revolution Medicines, Inc. (NASDAQ:RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced the company and its collaborators will present preclinical data at
Psyched: Canada’s Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More
Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism
A patient-led lawsuit against the Canadian government is claiming access to therapeutic psilocybin is a constitutional right under the Canadian Charter of Rights and Freedoms.
Tiziana Life Sciences Announces Invitation For Podium Presentation Of Research On Intranasal Anti-CD3 mAb In Intracerebral Hemorrhage At The Annual American Academy Of Neurology Conference
Dr. Saef Izzy's data shows one-month behavioral outcomes improvement in model of intracerebral hemorrhage (hemorrhagic stroke)
Modulation of neuroinflammation by inducing FoxP3+ Tregs appears to have beneficial